← Back to Clinical Trials
Recruiting NCT06880341

NCT06880341 Managing Transient Neurologic Episodes in Surgery for Moyamoya Disease

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06880341
Status Recruiting
Phase
Sponsor Stanford University
Condition Moya Moya Disease
Study Type OBSERVATIONAL
Enrollment 88 participants
Start Date 2025-05-21
Primary Completion 2026-12-31

Trial Parameters

Condition Moya Moya Disease
Sponsor Stanford University
Study Type OBSERVATIONAL
Phase N/A
Enrollment 88
Sex ALL
Min Age 3 Years
Max Age N/A
Start Date 2025-05-21
Completion 2026-12-31
Interventions
Standard of Care

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The goal of this study is to study the incidence of post-operative Transient Neurologic Events (TNEs) within 30 days postoperatively, as assessed by clinical neurological scales, binned by week. Collect data on all interventions and assessments performed during the recovery post surgery up to 30 days, to understand what factors might cause Transient Neurologic Events (TNEs) and determine how these can be reduced in Moyamoya subjects post surgery.

Eligibility Criteria

Inclusion Criteria: * Moyamoya Disease (MMD) patients undergoing direct extracranial-intracranial (ECIC) bypass. Patients above the age of 3 years old are eligible for the study Exclusion Criteria: * Renal dysfunction, electrolyte disturbances neuromuscular disorders including Myaesthenia Gravis, heart block

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology